NCT00213070|CompletedPhase 3
Loading search results
Sponsor study identifier
interventional
N/A
1 country
16
Study Start
Not reported
Date not reportedPrimary Completion
Not reported
Date not reportedStudy Completion
Not reported
Date not reportedThe purpose of this study is evaluate the clinical efficacy and safety of Miglitol in patients with Type2 Diabetes Mellitus with treated insulin.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 13, 2005
Actual (reported)September 21, 2005
Actual (reported)Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Aichi, Japan
Chiba, Japan
Fukuoka, Japan
Gifu, Japan
Gunma, Japan
Hokkaido, Japan
Ibaraki, Japan
Kagoshima, Japan
Clinical Promotion Group
Sanwa Kagaku Kenkyusho Co., Ltd.
First Submitted
September 13, 2005
First Posted
September 21, 2005
Last Updated
September 21, 2006
Record last verified: 2006-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin Treatment
Contact the study team to confirm eligibility.
Kanagawa, Japan
Kumamoto, Japan
Miyazaki, Japan
Okinawa, Japan
Ōita, Japan
Saitama, Japan
Shiga, Japan
Tokyo, Japan